Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients.
Clinical trial NCT06061536 · COMPLETED
Trial details
- NCT number
- NCT06061536
- Sponsor
- Shanxi Kangbao Biological Product Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-02
- Primary completion
- 2024-11-29
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.